Korean J Crit Care Med.  2015 Nov;30(4):299-302. 10.4266/kjccm.2015.30.4.299.

Catecholamine-Induced Cardiomyopathy associated with Neuroblastoma and Treated with Extracorporeal Membrane Oxygenation as a Bridge to Recovery

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, School of Medicine, Kyungpook National University, Daegu, Korea. hsuaa@naver.com
  • 2Department of Anesthesiology and Pain Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea.

Abstract

Catecholamine-induced cardiomyopathy associated with neuroblastoma is rarely reported. We report a case of catecholamine-induced cardiomyopathy associated with neuroblastoma in a 33-month-old female that was treated with extracorporeal membrane oxygenation (ECMO). She was tentatively diagnosed with acute myocarditis and presented with hypertension. Because of rapid patient deterioration despite pharmacological treatments, ECMO was applied. ECMO can be helpful in cases of catecholamine-induced cardiomyopathy associated with neuroblastoma.

Keyword

cardiomyopathies; catecholamines; extracorporeal membrane oxygenation; hypertension; myocarditis; neuroblastoma

MeSH Terms

Cardiomyopathies*
Catecholamines
Child, Preschool
Extracorporeal Membrane Oxygenation*
Female
Humans
Hypertension
Myocarditis
Neuroblastoma*
Catecholamines

Figure

  • Fig. 1. Preoperative plain chest radiograph shows cardiomegaly and bilateral alveolar infiltrates.

  • Fig. 2. Transesophageal echocardiography shows severe mitral regurgitation due to ruptured chordae tendineae. HR: heart rate.

  • Fig. 3. Thoracic and abdominal computed tomography angiography reveals a 4-cm, heterogeneous mass in the left kidney, consistent with neuroblastoma.


Reference

References

1. Singh HR, Paules M, Forbes TJ, Zilberman MV. Reversible dilated cardiomyopathy and neuroblastoma. J Pediatr. 2005; 147:271.
Article
2. Lee YH, Lee HD, Lee YA, Lee YS, Jung JA, Hwang GG, et al. Ganglioneuroblastoma presenting as dilated cardiomyopathy. Arch Dis Child. 2003; 88:162–4.
Article
3. Carlson P, Jefferies JL, Kearney D, Russell H. Refractory dilated cardiomyopathy associated with metastatic neuroblastoma. Pediatric Blood Cancer. 2010; 55:736–8.
Article
4. Kato M, Hirata S, Kikuchi A, Ogawa K, Kishimoto H, Hanada R. Neuroblastoma presenting with dilated cardiomyopathy. Pediatr Blood Cancer. 2008; 50:391–2.
Article
5. Kwok SY, Cheng FW, Lo AF, Leung WK, Yam MC, Li CK. Variants of cardiomyopathy and hypertension in neuroblastoma. J Pediatr Hematol Oncol. 2014; 36:e158–61.
Article
6. Sardesai SH, Mourant AJ, Sivathandon Y, Farrow R, Gibbons Do. Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. Br Heart J. 1990; 63:234–7.
Article
7. Suh IW, Lee CW, Kim YH, Hong MK, Lee JW, Kim JJ, et al. Catastrophic catecholamine-induced cardiomyopathy mimicking acute myocardial infarction, rescued by extracorporeal membrane oxygenation (ECMO) in Pheochromocytoma. J Korean Med Sci. 2008; 23:350–4.
Article
8. Shiraishi I, Nishimura K, Sakaguchi H, Abe T, Kitano M, Kurosaki K, et al. Acute rupture of chordate tendineae of the mitral valve in infants: a nationwide survey in Japan exploring a new syndrome. Circulation. 2014; 130:1053–61.
Full Text Links
  • KJCCM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr